Clinical Trials Browser

sintilimab × Tumor-Agnostic × 1 year × Clear all

NCT07455617 2026-04-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

Phase 1 Recruiting

Neoplasm Metastasis

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary